| 摘要 |
The invention relates to the use of klinoptilolith or klinoptilolith-containing mixtures for producing medicinal products or other pharmaceutical products, for the absorption and removal of caesium ions from the human or animal organism. Here, the klinoptilolith is modified by purification and comminution. The products are suitable, when taken in a preventative and/or timely manner, for reducing both the concentration of the absorption of radioactive caesium ions and also of non-radioactive caesium ions into the human or animal body. The medicinal product or pharmaceutical product is likewise suitable for reducing the caesium ions already present and absorbed in the living being when taken over a certain period, stepwise in the concentration after they have been taken. |
